Isoprostane 8-epi-prostaglandin F2α decreases lymph capillary pressure in patients with primary lymphedema

Journal of Vascular Research

Volumn 40, Issue 1, 2003, Pages 77-82

  Amann Vesti, Beatrice R ^a   Gitzelmann, Gabriele ^a   Koppensteiner, Renate ^a   Franzeck, Ulrich K ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

8 Epi prostaglandin F2 ; Fluorescence microlymphography; Lymph capillary pressure; Lymphedema; Microlymphatics

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; GLASS;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CAPILLARY PRESSURE; CLINICAL ARTICLE; COMPRESSION THERAPY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLUORESCENCE; HUMAN; LYMPHEDEMA; LYMPHOGRAPHY; MALE; MEASUREMENT; MICROPIPETTE; PRIORITY JOURNAL; VOLUNTEER;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; DEXTRANS; DINOPROST; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; LYMPHATIC SYSTEM; LYMPHEDEMA; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PLACEBOS; PRESSURE;

EID: 0037225288     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068942     Document Type: Article

References (31)

1. Bollinger A, Jäger K, Sgier F, Seglias J: Fluorescence microlymphography. Circulation 1981;64:1195-1200.
2. Isenring G, Franzeck UK, Bollinger A: Fluoreszenz-Mikrolymphographie am medialen Malleolus bei Gesunden und Patienten mit primärem Lymphödem. Schweiz Med Wochenschr 1982;112:225-231.
3. Bollinger A, Fagrell B: Clinical Capillaroscopy: A Guide to Its Use in Clinical Research and Practice. Toronto, Hoegrefe and Huber, 1990.
4. Bollinger A, Isenring G, Franzeck UK, Brunner U: Aplasia of superficial lymphatic capillaries in hereditary and connatal lymphedema (Milroy's disease). Lymphology 1983;16:27-30.
5. Pfister G, Saesseli B, Hoffmann U, Geiger M, Bollinger A: Diameters of lymphatic capillaries in patients with different forms of primary lymphedema. Lymphology 1990;23:140-144.
6. Jäger K, Isenring G, Bollinger A: Fluorescence microlymphography in patients with lymphedema and chronic venous incompetence. Inter Angio 1983;2:129-136.
7. Bollinger A, Isenring G, Franzeck UK: Lymphatic microangiopathy: A complication of severe chronic venous incompetence. Lymphology 1982;15:60-65.
8. Leu AJ, Gretener SB, Enderlin S, Brühlmann P, Michel BA, Kowal-Bielecka O, Hoffmann U, Franzeck UK: Lymphatic microangiopathy of the skin in systemic sclerosis. Rheumatology 1999;38:221-227.
9. Cliff S, Bedlow AJ, Stanton AWB, Mortimer PS: An in vivo study of the microlymphatics in psoriasis using fluorescence microlymphography. Br J Dermatol 1999;140:61-66
10. Spiegel M, Vesti B, Shore A, Franzeck UK, Becker F, Bollinger A: Pressure of lymphatic capillaries in human skin. Am J Physiol 1992;262:H1208-H1210.
11. Zaugg-Vesti B, Dörffler-Melly J, Spiegel M, Wen S, Franzeck UK, Bollinger A: Lymphatic capillary pressure in patients with primary lymphedema. Microvasc Res 1993;46:128-134.
12. Leu AJ, Berk DA, Yuan F, Jain RK: Flow velocity in the superficial lymphatic network of the mouse tail. Am J Physiol 1994;267:H1507-H1513.
13. Wen S, Dörffler-Melly J, Herrig I, Schiesser M, Franzeck UK, Bollinger A: Fluctuation of skin lymphatic capillary pressure in controls and in patients with primary lymphedema. Int J Microcirc Clin Exp 1994;14:139-143.
14. Franzeck UK, Dörffler J, Costanzo U, Bollinger A: Lymphatic capillary pressure in patients with secondary lymphedema (abstract). Int J Microcirc Clin Exp 1996;16(suppl 1):191.
15. Franzeck UK, Spiegel I, Fischer M, Börtzler C, Stahel HU, Bollinger A: Combined physical therapy for lymphedema evaluated by fluorescence microlymphography and lymph capillary pressure measurements. J Vasc Res 1997;34:306-311.
16. Johnston MG, Gordon JL: Regulation of lymphatic contractility by arachidonate metabolites. Nature 1981;293:294-297.
17. Sinzinger H, Oguogho A, Kaliman J: Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphatics. Lymphology 1997;30:155-159.
18. Sjöberg T, Alm P, Andersson KE, Norgren L, Stehen S: Contractile response in isolated human groin lymphatics. Lymphology 1987;20:152-160.
19. Wiederhelm CA, Weston BV: Microvascular, lymphatic, and tissue pressures in unanesthetized mammal. Am J Physiol 1973;225:992-996.
20. Intaglietta M, Pawula RF, Tompkins WR: Pressure measurements in the mammalian microvasculature. Microvasc Res 1970;2:212-220.
21. Morrow JD, Harris TM, Roberts LJ II: Noncy-clooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids. Anal Biochem 1990;184:1-10.
22. Morrow JD, Minton TA, Roberts LJ II: The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins 1992;44:155-163.
23. Kinmonth JB: The Lymphatics: Surgery, Lymphography and Diseases of the Chyle and Lymph Systems. London, Arnold, 1982.
24. Kubik S, Manestar M: Anatomy of the lymph capillaries and precollectors of the skin; in Bollinger A, Partsch H, Wolfe JHN (eds): The Initial Lymphatics: New Methods and Findings. Stuttgart, Thieme, 1985, pp 66-74.
25. Doerffler-Melly J, Schild D, Bollinger A, Franzeck UK: Diurnal and long-term variations of lymph capillary pressure in healthy subjects. Lymphology 1997;30:122-127.
26. Hall JG, Morris B, Woolley G: Intrinsic rhythmic propulsion of lymph in the unanaesthetized sheep. J Physiol 1965;283:457-468.
27. Olszewski WL, Engeset A: Intrinsic contractility of prenodal lymph vessels and lymph flow in human leg. Am J Physiol 1980;239:H775-H783.
28. Zhang JL, Yokoyama S, Ohhashi T: Inhibitory effects of fluorescein isothiocyanate photoactivation on lymphatic pump activity. Microvasc Res 1997;54:99-107.
29. Gardan B, Cracowski JL, Sessa C, Hunt M, Stanke-Labesque F, Devillier P, Bessard G: Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins. J Cardiovasc Pharmacol 2000;35:729-734.
30. Cracowski JL, Stanke-Labesque F, Devillier P, Chavanon O, Hunt M, Souvignet C, Bessard G: Human internal mammary artery contraction by isoprostaglandin F(2alpha) type-III [8-iso-prostaglandin F(2alpha)]. Eur J Pharmacol 2000;397:161-168.
31. Junger H, Sorkin LS: Isoprostanes induce plasma extravasation in rat skin. Prostaglandins Other Lipid Mediat 2000;62:335-342.